D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum: Aberrant ERK1/2 Signaling

Handbook of Behavioral Neuroscience

Volumn 20, Issue C, 2010, Pages 491-500

  Gerfen, Charles R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83155190715     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-374767-9.00028-7     Document Type: Chapter

References (37)

1. Albin, RL, Young, AB, Penney, JB, The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989), 366–375.
2. Aubert, I, Guigoni, C, Håkansson, K, Li, Q, Dovero, S, Barthe, N, Bioulac, BH, Gross, CE, Fisone, G, Bloch, B, Bezard, E, Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57 (2005), 17–26.
3. Bakay, RA, DeLong, MR, Vitek, JL, Posteroventral pallidotomy for Parkinson's disease. J Neurosurg 77 (1992), 487–498.
4. Bergmann, KJ, Mendoza, MR, Yahr, MD, Parkinson's disease and long-term levodopa therapy. Adv Neurol 45 (1987), 463–467.
5. Berke, JD, Paletzki, RF, Aronson, GJ, Hyman, SE, Gerfen, CR, A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci 18 (1998), 5301–5310.
6. Birkmayer, W, Hornykiewicz, O, The l-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 203 (1962), 560–574.
7. Brown, P, Gerfen, CR, Plasticity within striatal direct pathway neurons following neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK1/2/MAP Kinase pathway. J Comp Neurol 498 (2006), 415–430.
8. DeLong, MR, Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13 (1990), 281–285.
9. Gerfen, CR, Young, WS 3rd, Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460 (1988), 161–167.
10. Gerfen, CR, The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 246 (1989), 385–388.
11. Gerfen, CR, Engber, TM, Mahan, LC, Susel, Z, Chase, TN, Monsma, FJ Jr, Sibley, DR, D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990), 1429–1432.
12. Gerfen, CR, Miyachi, S, Paletzi, R, Brown, P, D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2MAPkinase. J Neurosci 22 (2002), 5042–5054.
13. Gerfen, CR, Paletzki, R, Worley, P, Differences between dorsal and ventral striatum in drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase. J Neurosci 28 (2008), 7113–7120.
14. Gong, S, Zheng, C, Doughty, ML, et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425 (2003), 917–925.
15. Gong, S, Doughty, M, Harbaugh, CR, Cummins, A, Hatten, ME, Heintz, N, Gerfen, CR, Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J Neurosci 27 (2007), 9817–9823.
16. Graybiel, AM, Moratalla, R, Robertson, HA, Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87 (1990), 6912–6916.
17. Hersch, SM, Ciliax, BJ, Gutekunst, CA, et al. Electron microscope analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15 (1995), 5222–5237.
18. Hyman, SE, Malenka, RC, Nestler, EJ, Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006), 565–598.
19. Keefe, KA, Gerfen, CR, D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J Comp Neurol 367 (1996), 165–176.
20. Konradi, C, Leveque, JC, Hyman, SEJ, Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. Neuroscience 16 (1996), 4231–4239.
21. LeMoine, C, Bloch, B, D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355 (1995), 418–426.
22. LeMoine, C, Normand, E, Guitteny, AF, Fouque, B, Teoule, R, Bloch, B, Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 87 (1990), 230–234.
23. Lozano, AM, Lang, AE, Hutchison, WD, Dostrovsky, JO, New developments in understanding the etiology of Parkinson's disease and in its treatment. Curr Opin Neurobiol 1998 (1998), 783–790.
24. Nadjar, A, Gerfen, CR, Bezard, E, Priming for 1-DOPA-induced dyskinesia in Parkinson's disease: A feature inherent to the treatment or the disease?. Prog Neurobiol 87 (2009), 1–9.
25. Pan, HS, Penney, JB, Young, AB, Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem 45 (1985), 1396–1404.
26. Robertson, GS, Vincent, SR, Fibiger, HC, Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res 523 (1990), 288–290.
27. Robertson, GS, Herrera, DG, Dragunow, M, Robertson, HA, 1-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur J Pharmacol 159 (1989), 99–100.
28. Santini, E, Valjent, E, Usiello, A, Carta, M, Borgkvist, A, Girault, JA, Herve, D, Greengard, P, Fisone, G, Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in 1-DOPA-induced dyskinesia. J Neurosci 27 (2007), 6995–7005.
29. Surmeier, DJ, Eberwine, J, Wilson, CJ, Cao, Y, Stefani, A, Kitai, ST, Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA 89 (1992), 10178–10182.
30. Steiner, H, Gerfen, CR, Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum J Neurosci 13 (1993), 5066–5081.
31. Steiner, H, Gerfen, CR, Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J Comp Neurol 376 (1996), 530–541.
32. Thomas, GM, Huganir, RL, MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5 (2004), 173–183.
33. Ungerstedt, U, Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367 (1971), 69–93.
34. Valjent, E, Corvol, JC, Pages, C, Besson, MJ, Maldonado, R, Caboche, J, Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 20 (2000), 8701–8709.
35. Valjent, E, Pascoli, V, Svenningsson, P, et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci USA 102 (2005), 491–496.
36. Westin, JE, Vercammen, L, Strome, EM, Konradi, C, Cenci, MA, Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of 1-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiatry 62 (2007), 800–810.
37. Young, WS, Bonner, TI, Brann, MR, Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83 (1986), 9827–9831.